SCHEMBL10815513

SCHEMBL10815513

COc1ccc2c(c1)c(CC(=O)OC(CN1CCN(CCCO)CC1)c1ccccc1)c(C)n2Cc1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.57
▸ LMNA P02545 2/20 0.57
▸ CYP1A2 P05177 2/20 0.57
▸ CYP3A4 P08684 2/20 0.57
▸ CYP2C9 P11712 2/20 0.57
▸ CYP2C19 P33261 2/20 0.57
▸ PMP22 Q01453 2/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ RGS12 O14924 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ PKM P14618 1/20 0.57
▸ NFKB1 P19838 1/20 0.57
▸ MAPK1 P28482 1/20 0.57
▸ GNAI1 P63096 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ HIF1A Q16665 1/20 0.57
▸ PLA2G2A P14555 11/20 0.52
▸ PLA2G1B P04054 1/20 0.52
▸ PTGS2 P35354 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10526172 0.88 PTGS2 (0.62) LMNACYP1A2CYP2C9PMP22MEN1
SCHEMBL10526127 0.85 PTGS2 (0.60) LMNACYP1A2CYP2C9PMP22MEN1
SCHEMBL10527799 0.83 PTGS2 (0.64) LMNACYP1A2CYP2C9PMP22MEN1
SCHEMBL10525264 0.77 PTGS2 (0.56) LMNACYP1A2CYP2C9PMP22MEN1
SCHEMBL10524337 0.76 PTGS2 (0.69) LMNACYP1A2CYP2C9PMP22MEN1
SCHEMBL10524488 0.76 PTGS2 (0.54) PTGS2
SCHEMBL10523837 0.76 PTGS2 (0.59) LMNACYP1A2CYP2C9PMP22MEN1
SCHEMBL10817893 0.75 LMNA (0.49) TSHRLMNACYP1A2CYP3A4CYP2C9
SCHEMBL9184235 0.75 PTGS2 (0.52) TSHRLMNACYP1A2CYP3A4CYP2C9
SCHEMBL1322507 0.74 LMNA (1.00) TSHRLMNACYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4696929-A Derivative of piperazine having anti-allergic and anti-inflammatory action TAIHO PHARMACEUTICAL COMPANY, LIMITED (JP) 1987-09-29 — — US disclosed
Send feedback